Post-earnings recap
Reported
Thu, Apr 29, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.06%, likely due to the lack of revenue details and ongoing supply chain issues. Investors may be cautious about future performance without clear guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.30 | N/A | +6.73% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in their product pipeline but acknowledged external challenges. They emphasized the importance of adapting to market conditions.
Management highlighted strong demand for sleep apnea products.
They noted ongoing challenges due to supply chain disruptions.
Focus remains on innovation and expanding market reach.